Nothing Special   »   [go: up one dir, main page]

NO872991L - Legemiddelbaerer med forsinket frigivelse av medikament. - Google Patents

Legemiddelbaerer med forsinket frigivelse av medikament.

Info

Publication number
NO872991L
NO872991L NO87872991A NO872991A NO872991L NO 872991 L NO872991 L NO 872991L NO 87872991 A NO87872991 A NO 87872991A NO 872991 A NO872991 A NO 872991A NO 872991 L NO872991 L NO 872991L
Authority
NO
Norway
Prior art keywords
medicine
pharmaceutical carrier
delayed release
sustained
drug
Prior art date
Application number
NO87872991A
Other languages
English (en)
Other versions
NO179163B (no
NO179163C (no
NO872991D0 (no
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO872991D0 publication Critical patent/NO872991D0/no
Publication of NO872991L publication Critical patent/NO872991L/no
Publication of NO179163B publication Critical patent/NO179163B/no
Publication of NO179163C publication Critical patent/NO179163C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO872991A 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse NO179163C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (4)

Publication Number Publication Date
NO872991D0 NO872991D0 (no) 1987-07-17
NO872991L true NO872991L (no) 1988-01-19
NO179163B NO179163B (no) 1996-05-13
NO179163C NO179163C (no) 1996-08-21

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872991A NO179163C (no) 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse

Country Status (13)

Country Link
US (1) US5030455A (no)
EP (1) EP0254978B1 (no)
JP (1) JPH0816066B2 (no)
KR (1) KR960004857B1 (no)
AT (1) ATE71291T1 (no)
CA (1) CA1309656C (no)
DE (1) DE3775850D1 (no)
DK (1) DK174931B1 (no)
ES (1) ES2040228T3 (no)
FI (1) FI96095C (no)
GR (1) GR3003536T3 (no)
NO (1) NO179163C (no)
PH (1) PH25286A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
ES2299173T3 (es) * 1993-12-13 2008-05-16 Avanir Pharmaceuticals Formulaciones de n-docosanol y ester de sacarosa.
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
US6417326B1 (en) * 1996-04-11 2002-07-09 The University Of British Columbia Fusogenic liposomes
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
NZ532435A (en) * 2001-11-30 2005-04-29 Pfizer Prod Inc Pharmaceutical compositions of 5,7,14-triazatetracyclo [10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
JP5539539B2 (ja) * 2010-12-08 2014-07-02 アイダエンジニアリング株式会社 高強度焼結成形体の製造方法およびその製造装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
ATE41740T1 (de) * 1984-08-30 1989-04-15 Rodisma Pharma Prod Gmbh Verfahren zur retardierung von vitamin c und e.

Also Published As

Publication number Publication date
DK174931B1 (da) 2004-03-01
GR3003536T3 (no) 1993-03-16
FI96095B (fi) 1996-01-31
DK373187A (da) 1988-01-19
DE3775850D1 (de) 1992-02-20
KR960004857B1 (ko) 1996-04-16
FI873106A (fi) 1988-01-19
JPS6327439A (ja) 1988-02-05
FI873106A0 (fi) 1987-07-14
DK373187D0 (da) 1987-07-17
EP0254978B1 (en) 1992-01-08
NO179163B (no) 1996-05-13
FI96095C (fi) 1996-05-10
ATE71291T1 (de) 1992-01-15
NO179163C (no) 1996-08-21
NO872991D0 (no) 1987-07-17
CA1309656C (en) 1992-11-03
JPH0816066B2 (ja) 1996-02-21
PH25286A (en) 1991-04-30
US5030455A (en) 1991-07-09
EP0254978A1 (en) 1988-02-03
KR880001301A (ko) 1988-04-22
ES2040228T3 (es) 1993-10-16

Similar Documents

Publication Publication Date Title
NO872991L (no) Legemiddelbaerer med forsinket frigivelse av medikament.
DE68901140D1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3778366D1 (de) Sich automatisch zerstoerende einweg-injektionsspritze.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3765243D1 (de) Ibuprofen und codein enthaltende, stabile, feste arzneimittel.
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
MC2025A1 (fr) Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
DK0460622T3 (da) Lægemiddelpræparat til systemisk behandling af pryd- og nyttefisk
RU92004357A (ru) Производные амида n-фенил-2-циано-3-оксикротоновой кислоты и их применение в качестве лекарственных средств с иммуномодуляторным действием
DE68905613D1 (de) Pharmazeutische zubereitung.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
DE3782594D1 (de) Arzneimittel zur transdermalen verabreichung von nicorandil.
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
ES2058316T3 (es) Procedimiento para la obtencion de un medicamento antitusigeno.
IT8719426A0 (it) Preparazione di amoxicillina iniettabile famraceutica.
ATE77820T1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
ATE64299T1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired